Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep38 | Adrenal cortex (to include Cushing's) | ECE2016

Moderate/severe Hypovolemic Hyponatremia with urinary sodium loss secondary to Hypoaldosteronism: analysis of 28 cases

Penso Rona , Ortola Ana , Amengual Angela , Crespo Irene , Ruiz-Gracia Teresa , Cuesta-Hernandez Martin , Gomez-Hoyos Emilia , Marcuello Clara , Calle Alfonso , Runkle Isabelle

Introduction: Hypoaldosteronism (HA), a cause of hypovolemic hyponatremia (HN) with urinary(U) sodium(Na) loss, is often underdiagnosed. We studied 28 patients with an episode of HA-induced moderate/severe hyponatremia.Methods: Retrospective 2012–2015. In all patients, Nadir(N) serum(S) Na <130 mmol/l (corrected for total proteins and glycemia), low internal yugular venous pressure, low ocular pressure. Addison’s Disease ruled (ACTH, cortis...

ea0041ep754 | Neuroendocrinology | ECE2016

The use of a specific protocol for initiation of tolvaptan therapy in mild/moderate euvolemic hyponatremia secondary to SIADH: not a single case of overcorrection

Amengual Angela , Ortola Ana , Crespo Irene , Penso Rona , Ruiz-Gracia Teresa , Gomez-Hoyos Emilia , Cuesta-Hernandez Martin , Santiago Alejandro , Calle Alfonso , Runkle Isabelle

Introduction: ESE guidelines state a risk for overcorrection of serum sodium levels (SNa) with vaptans. We present the results of our protocol for initiation of tolvaptan(TV) therapy in SIADH.Methods: Retrospective (2011–15). 86 patients with SIADH-induced mild/moderate hyponatremia received TV:7.5 mg day 1, ad-libitum liquids, no other Na-raising therapies. Conventional hospitalization (CH):66/86, day hospital (DH):20/86. Glycemia-corrected SNa det...

ea0037gp.03.05 | Adrenal (2) | ECE2015

Short-term blood pressure response to mineralocorticoid-receptor blockade in aldosteronisms: primary hyperaldosteronism vs aldosterone-associated hypertension/low-renin hypertension

Crespo Irene , Ruiz-Gracia Teresa , Ortola Ana , Gomez-Hoyos Emilia , Cuesta Martin , Barabash Ana , Saez-de Parayuelo Maria Victoria , Sanchez-Orta Marisol , Calle-Pascual Alfonso , Runkle Isabelle

Introduction: Some authors consider aldosteronism to be a spectrum, ranging from aldosterone-associated (or low-renin) hypertension (AAH) to primary hyperaldosteronism (PHA) due to bilateral adrenal hyperplasia. Thus, blood pressure (BP) response to mineralocorticoid-receptor blockade (MRB) could be similar.Methods: Retrospective analysis of 60 patients. Screening per Endocrine Society guidelines, positive screening: aldosterone (pg/ml) to direct-renin (...

ea0037ep672 | Pituitary: basic and neuroendocrinology | ECE2015

The use of an oral salt load followed by furosemide in the treatment of euvolemic SIADH-induced hyponatremia

Ortola Ana , Crespo Irene , Ruiz-Gracia Teresa , Gomez-Hoyos Emilia , Cuesta Martin , Penso Rona , Amengual Angela , de Miguel Paz , Calle-Pascual Alfonso , Runkle Isabelle

Introduction: Furosemide can be used in the treatment of SIADH. However, to be effective, renal medulla osmolality (OsmRM) as reflected in urinary osmolality (UOSM) must be high. Sodium is the most important contributor to OsmRM, which increases following the administration of oral salt. We analyze the use of an oral salt load followed by furosemide for the acute/short-term treatment of euvolemic SIADH hyponatremia.Method...

ea0037ep673 | Pituitary: basic and neuroendocrinology | ECE2015

Progressive reduction of tolvaptan doses in the treatment of chronic SIADH

Ruiz-Gracia Teresa , Ortola Ana , Crespo Irene , Santiago Alejando , Gomez-Hoyos Emilia , Recio Lourdes , Cuesta Martin , Paz Pacheco Maria , Calle-Pascual Alfonso , Runkle Isabelle

Introduction: Chronic tolvaptan (TV) therapy has been found to be safe and effective in the treatment of chronic SIADH. However, experience with modification of doses over time is limited.Methods: We conducted a retrospective analysis of weekly TV doses (mg) in 41 patients with chronic SIADH treated for a minimum of 3 months, seen a week following discharge and monthly thereafter. Serum sodium (SNa) goal was 137–140 mmol/l, with 50% TV dose reductio...

ea0032p708 | Neuroendocrinology | ECE2013

Hyponatremia in the emergency room: characteristics, and initial diagnostic approach

Cuesta Hernandez Martin , Gomez Hoyos Emilia , Fernandez Capel Francisco , Ruiz Gracia Teresa , Calle Pascual Alfonso , Martin Sanchez Javier , Runkle De La Vega Isabelle

Introduction: Hyponatremia is common in the emergency room, albeit frequently overlooked. Our objective was to describe the characteristics of hyponatremia in a cohort of emergency room patients, and evaluate how hyponatremia was studied and followed up.Material and methods: We studied all 211 patients under 70 years-of-age who presented/developed non-translocational hyponatremia (serum sodium (SNa) <135 mmol/l) during the first 48 h of their stay at...